On May 12th, Chen Mingye, director of the Policy Research Office of the Binhai New Area Innovation and Development Bureau, led Wang Jing, the senior director of biotechnology projects, to Joint Power Biotechnology Co., Ltd. and discussed the cartilage regeneration project with Yuan Jizu, General Manager of Anda Group, and Chen Ming, General Manager of Joint Power Through discussions and discussions, a preliminary consensus was reached on efforts to include the cartilage regeneration project in the pilot promotion plan of cell therapy in the free trade zone, and the opinions on arranging for district leaders to be invited to visit were put forward.

On June 10th, full-time deputy director of the China (Tianjin) Pilot Free Trade Zone Management Committee, deputy head of Tianjin Binhai New Area People’s Government and director of Binhai New Area Innovation and Development Bureau Yin Xiaofeng, led by Deputy Director of Innovation and Development Bureau Zhou Minhua, free trade zone airport area He Jiang, director of the work bureau, and staff from related departments came to Joint Power. They first visited the purification workshop and learned about the production process, and then had a long discussion in the conference room. Group General Manager Yuan Jizu first expressed welcome and thanks to Director Yin Xiaofeng and his delegation on behalf of Chairman Cui Hongjin, and introduced the overall situation of the group. Chen Ming, general manager of Joint Power, elaborated on the company's development history, technological leadership, safety and effectiveness, possible economic and social benefits, difficulties encountered before, and urgent problems to be solved, and answered everyone one by one. Question. Deputy District Chief Yin Xiaofeng fully recognized the cartilage regeneration technology. After analyzing the difficulties encountered by the company, he put forward specific solutions. He said: The joint dynamics technology is a good technology that benefits the people and can effectively solve the common people. The pain caused by osteoarthritis, but due to the lack of policy guidance, it has not been fully promoted. This time, it is necessary to break through the bottleneck through policy innovation, system innovation, and pioneering trials. The core problem of cell therapy is application, and only find applications Only when clinical experts approve and apply the scenarios can the real value be realized. In the next step, we must work hard to find clinical application scenarios for enterprises, and organize and coordinate relevant departments to do a good job of docking services. According to the suggestion put forward by the Deputy District Mayor Yin Xiaofeng, Joint Power Company cooperated with relevant departments to make a detailed plan to carry out docking work with three clinical hospitals in the free trade zone, and strive to realize clinical application as soon as possible. Wang Junpeng, assistant to the chairman of the group, also attended the meeting.